• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
"Hearing from all sides" How legislative testimony influences state level policy-makers in the United States.“多方声音”:美国立法证言如何影响州级政策制定者
Int J Health Policy Manag. 2015 Jan 9;4(2):91-8. doi: 10.15171/ijhpm.2015.13. eCollection 2015 Feb.
2
Comparison of Research Framing Preferences and Information Use of State Legislators and Advocates Involved in Cancer Control, United States, 2012-2013.2012 - 2013年美国参与癌症控制的州立法者与倡导者的研究框架偏好及信息使用情况比较
Prev Chronic Dis. 2017 Feb 2;14:E10. doi: 10.5888/pcd14.160292.
3
Communicating evidence-based information on cancer prevention to state-level policy makers.向州级政策制定者传达癌症预防的循证信息。
J Natl Cancer Inst. 2011 Feb 16;103(4):306-16. doi: 10.1093/jnci/djq529. Epub 2011 Jan 6.
4
Considering health and health disparities during state policy formulation: examining Washington state Health Impact Reviews.考虑在制定州政策时的健康和健康差距:审查华盛顿州健康影响评估。
BMC Public Health. 2019 Jul 3;19(1):862. doi: 10.1186/s12889-019-7165-7.
5
Policy makers' perspectives on tobacco control advocates' roles in regulation development.政策制定者对烟草控制倡导者在法规制定中作用的看法。
Tob Control. 2001 Sep;10(3):218-24. doi: 10.1136/tc.10.3.218.
6
Opportunities to improve policy dissemination by tailoring communication materials to the research priorities of legislators.通过根据立法者的研究重点定制宣传材料来改善政策传播的机会。
Implement Sci Commun. 2022 Mar 4;3(1):24. doi: 10.1186/s43058-022-00274-6.
7
Partisan differences in the effects of economic evidence and local data on legislator engagement with dissemination materials about behavioral health: a dissemination trial.党派差异对经济证据和当地数据影响立法者参与传播行为健康材料的作用:一项传播试验。
Implement Sci. 2022 Jun 22;17(1):38. doi: 10.1186/s13012-022-01214-7.
8
Factors Influencing Georgia Legislators' Decision-Making on Nurse Practitioner Scope of Practice.影响佐治亚州立法者关于执业护士执业范围决策的因素。
Policy Polit Nurs Pract. 2018 Dec 4:1527154418817036. doi: 10.1177/1527154418817036.
9
Predictors of state legislators' intentions to vote for cigarette tax increases.州立法者投票支持提高香烟税意图的预测因素。
Prev Med. 1998 Mar-Apr;27(2):157-65. doi: 10.1006/pmed.1998.0308.
10
Factors that explain how policy makers distribute resources to mental health services.解释政策制定者如何分配资源用于心理健康服务的因素。
Psychiatr Serv. 2003 Apr;54(4):501-7. doi: 10.1176/appi.ps.54.4.501.

引用本文的文献

1
Opportunities to improve policy dissemination by tailoring communication materials to the research priorities of legislators.通过根据立法者的研究重点定制宣传材料来改善政策传播的机会。
Implement Sci Commun. 2022 Mar 4;3(1):24. doi: 10.1186/s43058-022-00274-6.
2
Linking Data on Constituent Health with Elected Officials' Opinions: Associations Between Urban Health Disparities and Mayoral Officials' Beliefs About Health Disparities in Their Cities.将居民健康数据与民选官员意见相联系:城市健康差异与市长对本市健康差异看法之间的关联。
Milbank Q. 2021 Sep;99(3):794-827. doi: 10.1111/1468-0009.12501. Epub 2021 Mar 2.
3
Comparison of Research Framing Preferences and Information Use of State Legislators and Advocates Involved in Cancer Control, United States, 2012-2013.2012 - 2013年美国参与癌症控制的州立法者与倡导者的研究框架偏好及信息使用情况比较
Prev Chronic Dis. 2017 Feb 2;14:E10. doi: 10.5888/pcd14.160292.
4
Uses of Research Evidence by State Legislators Who Prioritize Behavioral Health Issues.重视行为健康问题的州立法者对研究证据的运用。
Psychiatr Serv. 2016 Dec 1;67(12):1355-1361. doi: 10.1176/appi.ps.201500443. Epub 2016 Jul 1.
5
Framing research for state policymakers who place a priority on cancer.为将癌症列为优先事项的州政策制定者构建研究框架。
Cancer Causes Control. 2016 Aug;27(8):1035-41. doi: 10.1007/s10552-016-0771-0. Epub 2016 Jun 14.

本文引用的文献

1
Communicating science in politicized environments.在政治化环境下传播科学。
Proc Natl Acad Sci U S A. 2013 Aug 20;110 Suppl 3(Suppl 3):14048-54. doi: 10.1073/pnas.1212726110. Epub 2013 Aug 12.
2
Evidence-based policy revisited: orientation towards the policy process and a public health policy science.循证政策再探讨:面向政策过程与公共卫生政策科学
Int J Public Health. 2012 Jun;57(3):455-7. doi: 10.1007/s00038-011-0321-1.
3
Evidence and argument in policymaking: development of workplace smoking legislation.政策制定中的证据与论证:工作场所吸烟立法的发展
BMC Public Health. 2009 Jun 17;9:189. doi: 10.1186/1471-2458-9-189.
4
Participation and argument in legislative debate on statewide smoking restrictions.参与关于全州范围内吸烟限制的立法辩论并进行论证。
Health Res Policy Syst. 2007 Oct 22;5:12. doi: 10.1186/1478-4505-5-12.
5
Factors influencing the utilization of research findings by health policy-makers in a developing country: the selection of Mali's essential medicines.影响发展中国家卫生政策制定者利用研究结果的因素:以马里基本药物的选择为例
Health Res Policy Syst. 2007 Mar 5;5:2. doi: 10.1186/1478-4505-5-2.
6
Using knowledge brokering to promote evidence-based policy-making: The need for support structures.利用知识中介促进循证决策:对支持结构的需求。
Bull World Health Organ. 2006 Aug;84(8):608-12. doi: 10.2471/blt.05.028308.
7
Advocacy coalitions and pharmacy policy in Denmark--solid cores with fuzzy edges.丹麦的倡导联盟与药学政策——边缘模糊的坚实核心
Soc Sci Med. 2006 Jul;63(1):212-24. doi: 10.1016/j.socscimed.2005.11.045. Epub 2006 Jan 24.
8
Systematically reviewing qualitative and quantitative evidence to inform management and policy-making in the health field.系统地审查定性和定量证据,以为卫生领域的管理和决策提供信息。
J Health Serv Res Policy. 2005 Jul;10 Suppl 1:6-20. doi: 10.1258/1355819054308576.
9
Health policy-makers' perceptions of their use of evidence: a systematic review.卫生政策制定者对其证据运用情况的认知:一项系统综述
J Health Serv Res Policy. 2002 Oct;7(4):239-44. doi: 10.1258/135581902320432778.
10
Power of information: closing the gap between research and policy.信息的力量:弥合研究与政策之间的差距。
Health Aff (Millwood). 2002 Mar-Apr;21(2):264-73. doi: 10.1377/hlthaff.21.2.264.

“多方声音”:美国立法证言如何影响州级政策制定者

"Hearing from all sides" How legislative testimony influences state level policy-makers in the United States.

机构信息

Center for Public Health Systems Science, Brown School, Washington University, St. Louis, MO, USA.

Prevention Research Center, Brown School,Washington University, St. Louis, MO, USA.

出版信息

Int J Health Policy Manag. 2015 Jan 9;4(2):91-8. doi: 10.15171/ijhpm.2015.13. eCollection 2015 Feb.

DOI:10.15171/ijhpm.2015.13
PMID:25674572
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4322632/
Abstract

BACKGROUND

This paper investigates whether state legislators find testimony influential, to what extent testimony influences policy-makers' decisions, and defines the features of testimony important in affecting policy-makers' decisions.

METHODS

We used a mixed method approach to analyze responses from 862 state-level legislators in the United States (U.S.). Data were collected via a phone survey from January-October, 2012. Qualitative data were analyzed using a general inductive approach and codes were designed to capture the most prevalent themes. Descriptive statistics and cross tabulations were also completed on thematic and demographic data to identify additional themes.

RESULTS

Most legislators, regardless of political party and other common demographics, find testimony influential, albeit with various definitions of influence. While legislators reported that testimony influenced their awareness or encouraged them to take action like conducting additional research, only 6% reported that testimony changes their vote. Among those legislators who found testimony influential, characteristics of the presenter (e.g., credibility, knowledge of the subject) were the most important aspects of testimony. Legislators also noted several characteristics of testimony content as important, including use of credible, unbiased information and data.

CONCLUSION

Findings from this study can be used by health advocates, researchers, and individuals to fine tune the delivery of materials and messages to influence policy-makers during legislative testimony. Increasing the likelihood that information from scholars will be used by policy-makers may lead to the adoption of more health policies that are informed by scientific and practice-based evidence.

摘要

背景

本文研究了州立法者是否认为证词具有影响力、证词在何种程度上影响政策制定者的决策,并确定了影响政策制定者决策的证词特征。

方法

我们采用混合方法分析了美国 862 名州级立法者的回应。数据于 2012 年 1 月至 10 月通过电话调查收集。定性数据采用一般归纳法进行分析,并设计了代码以捕捉最普遍的主题。还对主题和人口统计数据进行了描述性统计和交叉制表,以确定其他主题。

结果

大多数立法者,无论党派和其他常见人口统计学特征如何,都认为证词具有影响力,尽管对影响力的定义各不相同。虽然立法者报告说证词影响了他们的意识或鼓励他们采取额外的行动,如进行额外的研究,但只有 6%的人报告说证词改变了他们的投票。在那些认为证词有影响力的立法者中,演讲者的特征(如可信度、对主题的了解)是证词最重要的方面。立法者还指出证词内容的几个特征很重要,包括使用可信、无偏见的信息和数据。

结论

本研究的结果可被健康倡导者、研究人员和个人用来微调材料和信息的传递,以在立法证词中影响政策制定者。增加决策者使用学者信息的可能性,可能导致更多基于科学和实践证据的健康政策的通过。